OncLive® On Air
OncLive® On Air
In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.
Episodes
Mentioned books
Jul 15, 2024 • 11min
S10 Ep44: Curigliano on the DESTINY-Breast06 Trial in HER2-Low and -Ultralow Metastatic Breast Cancer
Dr Curigliano discusses the DESTINY-Breast06 trial of trastuzumab deruxtecan in patients with HER2-low or HER2-ultralow metastatic breast cancer.
Jul 11, 2024 • 10min
S10 Ep43: Orlowski on Isa-VRd in Transplant-Ineligible Multiple Myeloma
Dr Orlowski discusses key efficacy data from the IMROZ trial of Isa-VRd in newly diagnosed, transplant-ineligible multiple myeloma.
Jul 10, 2024 • 8min
S10 Ep42: Park and Sonpavde on Nivolumab Plus Gemcitabine/Cisplatin in Cisplatin-Eligible Urothelial Cancer
Drs Park and Sonpavde discuss the CheckMate901 trial, which showed survival improvements with nivolumab plus chemotherapy in metastatic urothelial cancer.
Jul 8, 2024 • 12min
S10 Ep41: ASCO 2024 Plenary: ADRIATIC Trial in Limited-Stage Small Cell Lung Cancer
OncLive On Air partners with Two Onc Docs to bring insights on the ADRIATIC trial, data from which were presented at the 2024 ASCO Annual Meeting.
Jul 1, 2024 • 8min
S10 Ep40: FDA Approval Insights: Imetelstat in Lower-Risk MDS and Transfusion-Dependent Anemia
The FDA's recent approval of imetelstat for treating lower-risk myelodysplastic syndromes and transfusion-dependent anemia takes center stage. Insights from the Phase III EMERGE trial showcase its ability to significantly improve red blood cell transfusion independence. The discussion also highlights a 40% rate of transfusion independence and remarkable hemoglobin enhancements among patients. Additionally, safety and management strategies for this innovative treatment reveal exciting future research possibilities, paving the way for broader patient access.
Jun 27, 2024 • 19min
S10 Ep39: Dietrich and Shiller Dive Into the Importance of Oncology Reflex Testing
Drs Dietrich and Shiller detail the importance of collaboration between medical oncologists and pathologists to ensure beneficial oncology reflex testing.
Jun 24, 2024 • 16min
S10 Ep38: Agulnik Highlights Key Updates in GIST Research and Management
Dr Agulnik spotlights key updates from across the GIST landscape ahead of GIST Awareness Day on July 13.
Jun 20, 2024 • 10min
S10 Ep37: Reckamp Discusses the Integration of Pragmatic Elements Into Oncology Clinical Trial Designs
Dr Reckamp discusses the definition of pragmatic clinical trials and ways that clinical trial investigators can make their research more pragmatic.
Jun 17, 2024 • 17min
S10 Ep36: Rosenberg Reviews the Evolving Role of Toripalimab in Nasopharyngeal Carcinoma
Dr Rosenberg discusses current standard strategies for treating patients with nasopharyngeal cancer, the evolving role of toripalimab in this treatment paradigm, and how future advances in nasopharyngeal cancer management may impact the head and neck cancer treatment paradigm more broadly.
Jun 10, 2024 • 12min
S10 Ep35: ASCO 2024 Plenary: LAURA Trial in Unresectable Stage III EGFRm NSCLC
OncLive On Air partners with Two Onc Docs to bring insights on primary data from the LAURA trial, which were presented at the 2024 ASCO Annual Meeting.
